Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling Up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali.

Context: In Mali, malaria transmission is seasonal, exposing children to high morbidity and mortality. A preventative strategy called Seasonal Malaria Chemoprevention (SMC) is being implemented, consisting of the distribution of drugs at monthly intervals for up to 4 months to children between 3 and 59 months of age during the period of the year when malaria is most prevalent. This study aimed to analyze the evolution of the incidence of malaria in the general population of the health districts of Kati, Kadiolo, Sikasso, Yorosso, and Tominian in the context of SMC implementation.

[Spatio-temporal analysis of the incidence of morbidity and mortality from severe malaria in the Sélingué health district, Mali].

Aims/objectives/assumption: In Mali, malaria is the leading cause of death and consultations in health facilities. The objective of this study was to examine trends in morbidity and mortality among children aged 0 to 15 years and to establish accurate mapping of the distribution of cases in health areas of the Sélingué health district.

Materials And Method: A retrospective analysis of hospital records at the Sélingué district reference health center from 2010 to 2013 was conducted.

[Clinical and epidemiological characteristic of COVID-19 deaths in Mali].

Introduction: Mali recorded its first COVID-19's death related case on March 26, 2020. The aim of this study was to evaluate the comorbidity of COVID-19's death related cases in the Malian context.

Method: A cross-sectional study was conducted between March 25 and October 11, 2020.

[Study on the clinical and epidemiological characteristics of the first 1030 cases of covid-19 in Mali].

Aims: Since the confirmation of the first cases of COVID-19 in Mali in March 2020 and the outbreakspreading to the whole country, clinical and epidemiological data fromaffected patients are used to characterize the disease. This study was to describe the clinica lsigns and epidemiologicalparameters of COVID-19 in the Malian context.

Materials And Methods: This is a cross-sectional study.

Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali.

Intermittent preventive treatment in pregnancy (IPTp) with 3 or more doses of sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organization to prevent malaria in pregnant women living in high-risk areas. According to the 2015 malaria indicator survey in Mali, malaria prevalence is 34.6%.

Discrepant prevalence and incidence of Leishmania infection between two neighboring villages in Central Mali based on Leishmanin skin test surveys.

Unlabelled: Apart from a single report, the last publication of cutaneous leishmaniasis (CL) in Mali dates back more than 20 years. The absence of information on the current status of CL in Mali led us to conduct a cohort study in Kemena and Sougoula, two villages in Central Mali from which cases of CL have been recently diagnosed by Mali's reference dermatology center in Bamako. In May 2006, we determined the baseline prevalence of Leishmania infection in the two villages using the leishmanin skin test (LST).